### Summary

This paper proposes a novel validation set construction method using synthetic data for early cancer detection in computed tomography (CT) volumes, specifically for liver tumors. The authors argue that traditional validation sets are limited by small size and domain specificity, leading to overfitting and poor generalization. To address this, they generate synthetic tumors and demonstrate that this approach improves model performance, especially for tiny tumors, and enhances continual learning frameworks by dynamically training on out-of-domain data.

### Soundness

2

### Presentation

2

### Contribution

2

### Strengths

1. The paper is well-organized, with clear figures and a straightforward presentation of the methodology and results.
2. The authors effectively use visualizations to demonstrate the differences between real and synthetic tumors, enhancing the reader's understanding of the proposed approach.

### Weaknesses

#### Some Related Works


#### comment

1. The paper's motivation is unclear and requires further clarification. The authors should provide a more detailed explanation of why they chose liver tumor segmentation and what specific challenges this application presents that justify their proposed method. The current justification, based on the potential for early detection, is not sufficiently compelling, and the paper lacks a clear articulation of the limitations of existing methods in this specific context. A more thorough discussion of the clinical relevance and the specific advantages of their approach over existing methods is needed.
2. The paper lacks a comprehensive comparison with other state-of-the-art methods in synthetic data generation and validation set construction. The authors should include a more extensive literature review and compare their method against established techniques, such as generative adversarial networks (GANs) or variational autoencoders (VAEs), to demonstrate the novelty and effectiveness of their approach. The absence of such comparisons makes it difficult to assess the true contribution of the proposed method.
3. The paper does not adequately address the potential biases introduced by the synthetic data generation process. The authors should discuss how the synthetic data might differ from real data and what steps they have taken to mitigate these biases. Specifically, the paper should address the potential for the synthetic data to oversimplify the complexity of real-world tumors, which could lead to models that perform poorly in clinical practice. The lack of discussion on this critical aspect undermines the reliability of the proposed method.
4. The paper's evaluation is limited to a single application (liver tumor segmentation) and does not explore the generalizability of the proposed method to other medical imaging tasks or datasets. The authors should demonstrate the versatility of their approach by applying it to other domains, such as lung cancer detection or prostate cancer segmentation, to show that the method is not specific to liver tumors. This would significantly strengthen the paper's claims and broaden its impact.

### Suggestions

To address the lack of clarity in the motivation, the authors should provide a more detailed explanation of the specific challenges in liver tumor segmentation that their method aims to solve. This should include a discussion of the limitations of existing methods, such as the scarcity of labeled data, the variability in tumor morphology, and the need for early detection. The authors should also clearly articulate why their synthetic data approach is better suited to overcome these limitations compared to other methods. For example, they could discuss how their method can generate a large number of diverse synthetic tumors, which can be used to augment the training data and improve the robustness of the model. Furthermore, the authors should provide a more detailed analysis of the clinical relevance of their method, including the potential impact on patient outcomes and the practical challenges of implementing their approach in a clinical setting. This would help to justify the significance of their work and its potential for real-world impact.

To strengthen the paper's contribution, the authors should include a more comprehensive comparison with other state-of-the-art methods in synthetic data generation and validation set construction. This should include a detailed discussion of the strengths and weaknesses of existing methods, as well as a quantitative comparison of their performance on the same dataset. The authors should also consider comparing their method against established techniques, such as generative adversarial networks (GANs) or variational autoencoders (VAEs), to demonstrate the novelty and effectiveness of their approach. This comparison should not only focus on the performance of the models but also on the computational cost and the complexity of the methods. The authors should also discuss the limitations of their method and the potential areas for improvement. This would provide a more balanced and objective assessment of the proposed method and its contribution to the field.

To address the potential biases introduced by the synthetic data generation process, the authors should provide a more detailed discussion of the steps they have taken to ensure the realism and diversity of the synthetic tumors. This should include a discussion of the parameters used in the synthetic data generation process and how they were chosen. The authors should also discuss the potential for the synthetic data to oversimplify the complexity of real-world tumors and how they have mitigated this issue. For example, they could discuss how they have ensured that the synthetic tumors capture the variability in tumor morphology, size, and location. Furthermore, the authors should provide a more detailed analysis of the impact of the synthetic data on the performance of the model. This should include an analysis of the model's performance on real-world data and the potential for the synthetic data to introduce biases. This would help to ensure that the proposed method is reliable and robust.

### Questions

1. How does the proposed method compare to other synthetic data generation techniques in terms of performance and generalizability?
2. What measures have been taken to ensure the realism and diversity of the synthetic tumors generated, and how might this affect the model's performance on real-world data?

### Rating

3

### Confidence

4

**********
